Arachidonic acid level is related to early motor recovery following intracerebral hemorrhage with severe motor paralysis.

Arachidonic acid Intracerebral hemorrhage Neural stem cells Paralysis Polyunsaturated fatty acids Stroke

Journal

Prostaglandins, leukotrienes, and essential fatty acids
ISSN: 1532-2823
Titre abrégé: Prostaglandins Leukot Essent Fatty Acids
Pays: Scotland
ID NLM: 8802730

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 16 11 2023
revised: 09 12 2023
accepted: 12 12 2023
medline: 27 12 2023
pubmed: 27 12 2023
entrez: 26 12 2023
Statut: aheadofprint

Résumé

Low arachidonic acid (AA) levels are reportedly associated with unfavorable outcomes in intracerebral hemorrhage (ICH). We aimed to clarify whether serum AA levels might be associated with a good recovery from severe motor paralysis in the early stage of hospitalization. From among consecutive ICH patients between October 2012 and December 2021, patients with a sum of upper and lower extremity National Institutes of Health stroke scale (NIHSS) scores of 4-8 at admission (severe motor paralysis) were included. We defined good early recovery from severe motor paralysis as a sum of upper and lower extremity NIHSS scores of 0-3 on day 7 after admission, and that of individual upper and lower extremities as NIHSS scores of 0-1 on day 7 after admission. We aimed to assess whether serum AA levels might be associated with good early recovery from severe motor paralysis. We screened 377 consecutive ICH patients, including 140 with severe motor paralysis (88 (63%) males, median age 64 years). Recovery from severe motor paralysis was seen in 48 (34%). Higher AA levels (PR 1.243, 95% CI 1.042 to 1.483, p = 0.016) were independently associated with good overall recovery, and good recovery of upper and lower extremities separately (upper extremity: PR 1.319, 95% CI 1.101 to 1.580, p = 0.003; lower extremity: PR 1.293, 95% CI 1.115 to 1.499, p = 0.001). Higher AA levels may contribute to a good early motor recovery in patients with severe motor paralysis due to ICH.

Sections du résumé

BACKGROUND BACKGROUND
Low arachidonic acid (AA) levels are reportedly associated with unfavorable outcomes in intracerebral hemorrhage (ICH).
OBJECTIVE OBJECTIVE
We aimed to clarify whether serum AA levels might be associated with a good recovery from severe motor paralysis in the early stage of hospitalization.
METHODS METHODS
From among consecutive ICH patients between October 2012 and December 2021, patients with a sum of upper and lower extremity National Institutes of Health stroke scale (NIHSS) scores of 4-8 at admission (severe motor paralysis) were included. We defined good early recovery from severe motor paralysis as a sum of upper and lower extremity NIHSS scores of 0-3 on day 7 after admission, and that of individual upper and lower extremities as NIHSS scores of 0-1 on day 7 after admission. We aimed to assess whether serum AA levels might be associated with good early recovery from severe motor paralysis.
RESULTS RESULTS
We screened 377 consecutive ICH patients, including 140 with severe motor paralysis (88 (63%) males, median age 64 years). Recovery from severe motor paralysis was seen in 48 (34%). Higher AA levels (PR 1.243, 95% CI 1.042 to 1.483, p = 0.016) were independently associated with good overall recovery, and good recovery of upper and lower extremities separately (upper extremity: PR 1.319, 95% CI 1.101 to 1.580, p = 0.003; lower extremity: PR 1.293, 95% CI 1.115 to 1.499, p = 0.001).
CONCLUSIONS CONCLUSIONS
Higher AA levels may contribute to a good early motor recovery in patients with severe motor paralysis due to ICH.

Identifiants

pubmed: 38147805
pii: S0952-3278(23)00072-8
doi: 10.1016/j.plefa.2023.102603
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102603

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

Auteurs

Takeo Sato (T)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: takeo.sato.821@gmail.com.

Motohiro Okumura (M)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Junichiro Takahashi (J)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Tatsushi Kokubu (T)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Maki Tanabe (M)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Asako Onda (A)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Teppei Komatsu (T)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Kenichi Sakuta (K)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Kenichiro Sakai (K)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Tadashi Umehara (T)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Hidetaka Mitsumura (H)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Masato Matsushima (M)

Division of Clinical Epidemiology, Research Center for Medical Sciences, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.

Yasuyuki Iguchi (Y)

Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan.

Classifications MeSH